These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34623544)

  • 61. Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS1 β-cells.
    Petcherski A; Trudeau KM; Wolf DM; Segawa M; Lee J; Taddeo EP; Deeney JT; Liesa M
    J Mol Biol; 2018 Dec; 430(24):4823-4833. PubMed ID: 30389435
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome.
    Kiebish MA; Yang K; Liu X; Mancuso DJ; Guan S; Zhao Z; Sims HF; Cerqua R; Cade WT; Han X; Gross RW
    J Lipid Res; 2013 May; 54(5):1312-25. PubMed ID: 23410936
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
    Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Novel mutations in the TAZ gene in patients with Barth syndrome.
    Mazurová S; Tesařová M; Magner M; Houšťková H; Hansíková H; Augustínová J; Tomek V; Vondráčková A; Zeman J; Honzík T
    Prague Med Rep; 2013; 114(3):139-53. PubMed ID: 24093814
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Barth syndrome, a human disorder of cardiolipin metabolism.
    Schlame M; Ren M
    FEBS Lett; 2006 Oct; 580(23):5450-5. PubMed ID: 16973164
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neurological & psychological aspects of Barth syndrome: Clinical manifestations and potential pathogenic mechanisms.
    Olivar-Villanueva M; Ren M; Phoon CKL
    Mitochondrion; 2021 Nov; 61():188-195. PubMed ID: 34197965
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mitochondrial dysfunctions in barth syndrome.
    Ghosh S; Iadarola DM; Ball WB; Gohil VM
    IUBMB Life; 2019 Jul; 71(7):791-801. PubMed ID: 30746873
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metabolic Alterations Caused by Defective Cardiolipin Remodeling in Inherited Cardiomyopathies.
    Wasmus C; Dudek J
    Life (Basel); 2020 Nov; 10(11):. PubMed ID: 33187128
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome.
    Vreken P; Valianpour F; Nijtmans LG; Grivell LA; Plecko B; Wanders RJ; Barth PG
    Biochem Biophys Res Commun; 2000 Dec; 279(2):378-82. PubMed ID: 11118295
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
    Ye C; Shen Z; Greenberg ML
    J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tetra-linoleoyl cardiolipin depletion plays a major role in the pathogenesis of sarcopenia.
    Semba RD; Moaddel R; Zhang P; Ramsden CE; Ferrucci L
    Med Hypotheses; 2019 Jun; 127():142-149. PubMed ID: 31088638
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effects of a mitochondrial targeted peptide (elamipretide/SS31) on BAX recruitment and activation during apoptosis.
    Grosser JA; Fehrman RL; Keefe D; Redmon M; Nickells RW
    BMC Res Notes; 2021 May; 14(1):198. PubMed ID: 34022923
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Case report: Variability in clinical features as a potential pitfall for the diagnosis of Barth syndrome.
    Tovaglieri N; Russo S; Micaglio E; Corcelli A; Lobasso S
    Front Pediatr; 2023; 11():1250772. PubMed ID: 37654687
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
    Hsu P; Liu X; Zhang J; Wang HG; Ye JM; Shi Y
    Autophagy; 2015 Apr; 11(4):643-52. PubMed ID: 25919711
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice.
    Zhao W; Xu Z; Cao J; Fu Q; Wu Y; Zhang X; Long Y; Zhang X; Yang Y; Li Y; Mi W
    J Neuroinflammation; 2019 Nov; 16(1):230. PubMed ID: 31747905
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Barth syndrome.
    Clarke SL; Bowron A; Gonzalez IL; Groves SJ; Newbury-Ecob R; Clayton N; Martin RP; Tsai-Goodman B; Garratt V; Ashworth M; Bowen VM; McCurdy KR; Damin MK; Spencer CT; Toth MJ; Kelley RI; Steward CG
    Orphanet J Rare Dis; 2013 Feb; 8():23. PubMed ID: 23398819
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Advances in the understanding of Barth syndrome.
    Aprikyan AA; Khuchua Z
    Br J Haematol; 2013 May; 161(3):330-8. PubMed ID: 23432031
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Barth syndrome and the many fascinating aspects of cardiolipin.
    Vaz FM; Wanders RJA; Vernon H
    J Inherit Metab Dis; 2022 Jan; 45(1):1-2. PubMed ID: 34855207
    [No Abstract]   [Full Text] [Related]  

  • 79. Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts.
    Valianpour F; Wanders RJ; Overmars H; Vreken P; Van Gennip AH; Baas F; Plecko B; Santer R; Becker K; Barth PG
    J Pediatr; 2002 Nov; 141(5):729-33. PubMed ID: 12410207
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diverse mitochondrial abnormalities in a new cellular model of TAFFAZZIN deficiency are remediated by cardiolipin-interacting small molecules.
    Anzmann AF; Sniezek OL; Pado A; Busa V; Vaz FM; Kreimer SD; DeVine LR; Cole RN; Le A; Kirsch BJ; Claypool SM; Vernon HJ
    J Biol Chem; 2021 Sep; 297(3):101005. PubMed ID: 34314685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.